Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rachel Clark Sisodia, M.D.

Concepts (247)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genital Neoplasms, Female1020245323.080 Why?
Fallopian Tube Neoplasms520223281.790 Why?
Ovarian Neoplasms19202348531.730 Why?
Carcinoma, Endometrioid920232761.380 Why?
Vulvar Neoplasms420242631.050 Why?
Peritoneal Neoplasms520237100.980 Why?
Endometrial Neoplasms11202313650.930 Why?
Hysterectomy620228560.800 Why?
Carcinosarcoma620231060.790 Why?
Anesthesia Department, Hospital12021690.710 Why?
Uterine Neoplasms8202314200.660 Why?
Sexual Dysfunction, Physiological120213600.610 Why?
Neoplasms, Glandular and Epithelial320154870.590 Why?
Genetic Counseling120206280.530 Why?
Physicians, Primary Care120216180.470 Why?
Social Support1202321750.420 Why?
Psychometrics2202130610.410 Why?
Electronic Health Records5202248130.410 Why?
Adenocarcinoma, Clear Cell320232170.400 Why?
Cystadenocarcinoma, Serous520234750.400 Why?
Fallopian Tubes220221780.390 Why?
Lymph Node Excision7202312690.390 Why?
Pelvis420237340.360 Why?
Data Collection1202033190.360 Why?
Anesthesiology1202111210.360 Why?
Healthcare Disparities2202333520.350 Why?
Uterine Cervical Neoplasms4202320200.320 Why?
Menotropins12008410.320 Why?
Quality of Life82023133620.310 Why?
Neoplasms, Cystic, Mucinous, and Serous220151940.310 Why?
Female6120243924580.300 Why?
Ovary220229570.300 Why?
Anxiety1202145720.270 Why?
Ovarian Follicle120082440.270 Why?
Ovulation Induction120082770.270 Why?
Follicle Stimulating Hormone120087260.260 Why?
Humans7320247610980.240 Why?
Neoplasm Staging182023111180.240 Why?
Massachusetts4202388360.240 Why?
Antineoplastic Combined Chemotherapy Protocols82023117320.230 Why?
SEER Program10201614500.230 Why?
Lymph Nodes4202134610.220 Why?
Cystadenocarcinoma, Papillary12023560.220 Why?
Health Status Indicators220219700.210 Why?
Middle Aged3220232208350.200 Why?
Fallopian Tube Diseases12022600.200 Why?
Delivery of Health Care1202053330.200 Why?
Carcinoma1201323280.190 Why?
Aged3120231692660.190 Why?
Teratoma120144040.190 Why?
Osteoarthritis, Knee2202212350.190 Why?
Pandemics1202186630.190 Why?
Ovarian Diseases120221360.190 Why?
Arthroplasty, Replacement, Knee2202213940.180 Why?
Morpholines120145810.180 Why?
Sentinel Lymph Node Biopsy220227320.170 Why?
Metrorrhagia12010170.170 Why?
Surgical Procedures, Operative2202219230.170 Why?
Retrospective Studies222023806730.170 Why?
Chemotherapy, Adjuvant5202335120.170 Why?
Aminopyridines120145730.170 Why?
Receptors, N-Methyl-D-Aspartate120148940.160 Why?
Medical Oncology3201923160.160 Why?
Aged, 80 and over152023589460.160 Why?
Health Education1201510490.160 Why?
Patient Readmission1201332680.160 Why?
Neoplasm, Residual2202110080.160 Why?
Genetic Predisposition to Disease12020178890.150 Why?
Hydatidiform Mole120102550.150 Why?
Osteoarthritis, Hip120224090.150 Why?
Attitude of Health Personnel2202238820.140 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis120213800.140 Why?
Health Facilities120225750.140 Why?
Specialties, Surgical120223890.140 Why?
Maternal Age120108090.140 Why?
Neoplasm Recurrence, Local4202192780.140 Why?
Risk Adjustment120206010.140 Why?
Referral and Consultation3202036030.140 Why?
Activities of Daily Living2202224200.130 Why?
Prospective Studies52023544190.130 Why?
Adult1920232210830.120 Why?
Postoperative Care1202214690.120 Why?
Proto-Oncogene Proteins c-akt1201424550.120 Why?
Gynecologic Surgical Procedures220152840.120 Why?
TOR Serine-Threonine Kinases1201420570.120 Why?
Burnout, Professional120237030.120 Why?
Lymphatic Metastasis5202229130.120 Why?
Precancerous Conditions120219820.120 Why?
Neoadjuvant Therapy4202328270.120 Why?
Disability Evaluation1202118340.120 Why?
Immunity, Cellular1201015530.110 Why?
Survival Rate102016127270.110 Why?
Patient Positioning120163260.110 Why?
Kaplan-Meier Estimate7201664820.110 Why?
Academic Medical Centers2202227570.110 Why?
Program Evaluation1202224870.110 Why?
Myometrium120141740.110 Why?
Ileus12013660.110 Why?
Placenta Accreta120162370.100 Why?
Epithelial Cells1201436660.100 Why?
Intraoperative Care120167670.100 Why?
Video Recording120179650.100 Why?
Self Care120177950.100 Why?
Perioperative Period120132520.100 Why?
Adenocarcinoma, Mucinous120165170.100 Why?
Patient Acceptance of Health Care1201531970.100 Why?
Cohort Studies52022414860.100 Why?
Early Detection of Cancer1201531960.090 Why?
Length of Stay4202264200.090 Why?
Leiomyosarcoma120154220.090 Why?
Health Knowledge, Attitudes, Practice1201540130.090 Why?
Carcinoma, Transitional Cell220167820.090 Why?
Education, Medical, Graduate1201223720.090 Why?
Developing Countries1201228620.090 Why?
Sarcoma1202118000.090 Why?
Pleural Effusion120133410.090 Why?
Proportional Hazards Models72016124670.090 Why?
Radiotherapy, Adjuvant1201517840.080 Why?
Diagnostic Errors1201612650.080 Why?
Analgesics, Opioid2202338080.080 Why?
Gynecology120155260.080 Why?
Hospitals1202238810.080 Why?
Clomiphene12008710.080 Why?
Radiology1202221140.080 Why?
Combined Modality Therapy5201785190.080 Why?
Fertility Agents, Female120081010.080 Why?
Carcinoma, Papillary120137850.070 Why?
Opioid-Related Disorders1202321640.070 Why?
Intraoperative Complications1201411650.070 Why?
Carcinoma, Squamous Cell2201340210.070 Why?
Disease-Free Survival4201668170.070 Why?
Pregnancy, Multiple120082150.070 Why?
Carboplatin220167930.070 Why?
Health Personnel1202133350.070 Why?
Prognosis92016296720.070 Why?
Patient Education as Topic1201723160.070 Why?
Paclitaxel2201417300.070 Why?
Patients220239060.070 Why?
Luteinizing Hormone120088200.060 Why?
Image Enhancement1201628880.060 Why?
Patient Discharge2202334410.060 Why?
Physicians1202345830.060 Why?
Pregnancy Rate120086480.060 Why?
Postoperative Period2202218180.060 Why?
Decision Support Techniques1201420000.060 Why?
Platinum Compounds12014950.060 Why?
Radiotherapy3201614980.060 Why?
Surgical Wound Infection1201315300.060 Why?
Paget Disease, Extramammary12024510.060 Why?
United States112023723370.060 Why?
Neoplasm Invasiveness3201635910.050 Why?
Phosphatidylinositol 3-Kinase120141260.050 Why?
Morphine Derivatives12023420.050 Why?
Young Adult42023591990.050 Why?
Treatment Outcome52021646700.050 Why?
Organoplatinum Compounds220154070.050 Why?
Pregnancy52019298720.050 Why?
Reoperation1201343040.050 Why?
Population Groups120232070.050 Why?
Venous Thromboembolism1201518680.050 Why?
Pain, Postoperative2202317380.050 Why?
Mortality1201328960.050 Why?
Adenocarcinoma2202463400.050 Why?
Hydromorphone12022700.050 Why?
Qualitative Research2202230160.050 Why?
Genes, BRCA1120147540.050 Why?
Decompression12020360.050 Why?
Signal Transduction12014234150.040 Why?
Endometrial Hyperplasia12021970.040 Why?
Electrocoagulation120201520.040 Why?
Pulmonary Embolism1201325710.040 Why?
Multivariate Analysis22014120580.040 Why?
Class I Phosphatidylinositol 3-Kinases120148990.040 Why?
Job Satisfaction120235450.040 Why?
Papillomavirus Vaccines120154960.040 Why?
Suction120202660.040 Why?
Health Priorities120223750.040 Why?
Mice, SCID1201426210.040 Why?
PTEN Phosphohydrolase1201411110.040 Why?
Time Factors32015399530.040 Why?
Postoperative Complications22021156340.040 Why?
New England1201010500.030 Why?
Parity120109240.030 Why?
Aminopterin12016150.030 Why?
Aftercare120239130.030 Why?
Cell Count1201018310.030 Why?
Algorithms12016140230.030 Why?
Carcinoma in Situ120217910.030 Why?
Xenograft Model Antitumor Assays1201435910.030 Why?
Germ-Line Mutation1202318520.030 Why?
Laparotomy120174560.030 Why?
Phosphatidylinositol 3-Kinases1201428640.030 Why?
Remission Induction1201023920.030 Why?
Fellowships and Scholarships1201211160.030 Why?
Lower Extremity1202212010.030 Why?
Intraoperative Period120155100.030 Why?
Follow-Up Studies42016391210.030 Why?
Papillomavirus Infections1201516150.030 Why?
Guidelines as Topic1202013860.030 Why?
Age Factors32015183850.030 Why?
Knee Joint1202216770.030 Why?
Drug Resistance, Neoplasm2202153000.030 Why?
Tissue Distribution1201622620.030 Why?
Myocardial Infarction12013114750.020 Why?
Odds Ratio1202396480.020 Why?
Reproducibility of Results22021201200.020 Why?
Male420233606750.020 Why?
Immunohistochemistry12014110660.020 Why?
Feasibility Studies1202252490.020 Why?
Blood Loss, Surgical120146370.020 Why?
Emotions1202227400.020 Why?
Neutropenia120158850.020 Why?
Logistic Models22014132540.020 Why?
Contrast Media1202253110.020 Why?
Magnetic Resonance Imaging12016364180.020 Why?
Heart Failure12013117010.020 Why?
Low Back Pain120179830.020 Why?
Tumor Burden1201418920.020 Why?
Age Distribution1201328730.020 Why?
Drug Administration Schedule1201548490.020 Why?
Risk Assessment22021240130.020 Why?
Medicare2201567750.020 Why?
Quality of Health Care1202243190.020 Why?
Quality Improvement1202138010.020 Why?
Neoplasm Metastasis1201649080.020 Why?
Anemia1201515040.020 Why?
Laparoscopy1201720300.020 Why?
Antineoplastic Agents22015136300.010 Why?
Skin Neoplasms1202458090.010 Why?
Survival Analysis12017100830.010 Why?
Heart Rate1201441960.010 Why?
Risk1201496140.010 Why?
Health Status1201540770.010 Why?
Health Status Disparities1201318460.010 Why?
Sensitivity and Specificity12016146760.010 Why?
Diagnosis, Differential12016129750.010 Why?
Databases, Factual1201679690.010 Why?
Mutation12014300060.010 Why?
Blood Pressure1201484780.010 Why?
Tomography, X-Ray Computed12022206000.010 Why?
Breast Neoplasms12014209810.010 Why?
Registries1201382360.010 Why?
Mice12014813240.010 Why?
Incidence12015213570.010 Why?
Adolescent12014882710.010 Why?
Case-Control Studies12014221570.010 Why?
Animals120141680830.010 Why?
Sisodia's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (247)
Explore
_
Co-Authors (92)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.